Status:
UNKNOWN
Identification of Biomarkers of Response After Bariatric Surgery in Morbidly Obese Patients
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
Morbid Obesity
Eligibility:
All Genders
18-65 years
Brief Summary
The prevalence of obesity in Spain is about 21.6%. The discouraging results provided by dietary treatment, together with the lack of funding for pharmacological treatment, have led to the progressive ...
Detailed Description
The investigators have designed a prospective study in which 200 consecutive patients from the outpatient clinic of the Morbidly Obesity Unit of the Vall d'Hebron Hospital will be included, meeting cr...
Eligibility Criteria
Inclusion
- Patients fulfilling criteria for bariatric surgery (BS).
- Signed informed consent fir the BS and the study.
- Previous accomplishment of the preoperative protocol for the BS at our site.
- undergo BS between September 2018 and December 2019
- Able to read and understand the specific questionnaires.
Exclusion
- Any contraindication for the bariatric surgery.
- Impossibility to follow-up at our site (eg: patients from outside out community).
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03784508
Start Date
April 1 2018
End Date
April 1 2022
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andreea Ciudin
Barcelona, Spain, 08035